Business Description
Akebia Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00972D1054
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.89 | |||||
Equity-to-Asset | -0.13 | |||||
Debt-to-Equity | -1.57 | |||||
Debt-to-EBITDA | -14.21 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.42 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -21.3 | |||||
3-Year EBITDA Growth Rate | 79.3 | |||||
3-Year EPS without NRI Growth Rate | 53.7 | |||||
3-Year FCF Growth Rate | 46.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.85 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.18 | |||||
9-Day RSI | 31.76 | |||||
14-Day RSI | 37.79 | |||||
6-1 Month Momentum % | 143.07 | |||||
12-1 Month Momentum % | 152.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.18 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 96.62 | |||||
Days Sales Outstanding | 52.3 | |||||
Days Payable | 65.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.5 | |||||
Shareholder Yield % | 19.85 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.29 | |||||
Operating Margin % | -23.32 | |||||
Net Margin % | -26.32 | |||||
FCF Margin % | -12.01 | |||||
ROA % | -18.8 | |||||
ROIC % | -21.84 | |||||
ROC (Joel Greenblatt) % | -170.32 | |||||
ROCE % | -25.73 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.31 | |||||
EV-to-EBIT | -6.35 | |||||
EV-to-EBITDA | -84.79 | |||||
EV-to-Revenue | 1.47 | |||||
EV-to-Forward-Revenue | 1.5 | |||||
EV-to-FCF | -12.22 | |||||
Earnings Yield (Greenblatt) % | -15.75 | |||||
FCF Yield % | -8.42 |